Leading surgeon and professor Dr. Mark Holterman strives to bring more attention to the cutting-edge medical treatments that are available. As a result, Holterman has played a key role in creating the Sunshine Foundation and the Alliance for the Advancement of Cellular Therapies. Both foundations seek to help cure patients through a specific type of stem cell therapy.
The stem cells described by Dr. Mark Holterman can be found everywhere throughout the human body and may be an important factor in helping patients to overcome degenerative diseases. With trial therapies working especially well on younger individuals, this stem cell therapy shows promise of being able to help patients heal faster and resist cell degeneration. Funding for this type of research comes from numerous sources, including the 21st Century Cures Act.
Legislation under the 21st Century Cures Act was passed in the United States in 2016 and supports medical research with billions of dollars in funding assistance. This act directly relates to the pursuits of Dr. Mark Holterman because it boosts the available support for stem cell research and regenerative medicine in general. The 21st Century Cures Act is also dedicated to combating the opioid epidemic in the United States by dedicating at least $2 billion in designated funds.
Dr. Mark Holterman started his education at Yale University, where he graduated with a major in biology. He continued postgraduate studies through the University of Virginia and received both his M.D. and Ph.D. from the school. Dr. Mark Holterman remained at the University of Virginia complete his residency at its Health Sciences division and also finished a fellowship at Children’s Hospital. Holterman’s specific focus is in the field of pediatric surgery.
Since 2011, Dr. Mark Holterman has been working at the College of Medicine at the University of Illinois as a full professor (Vitals). He spends much time serving as a pediatric surgeon at numerous children’s hospitals in the state of Illinois as well. Holterman has a keen interest in innovative medical practices that include stem cell research and the science of regenerative medicine. He is a member of multiple healthcare professional organizations.